You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology
On demand events
Bullous Pemphigoid: Exploring New Frontiers
Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).
MD, PhD
Joost Meijer +3 more
On demand materials
Learning objectives
- Describe the heterogenous clinical presentations, disease burden, and diagnosis of BP
- Highlight current understanding of BP pathophysiology and the critical role of autoimmunity and type 2 inflammation in both clinical signs and itch
- Discuss unmet needs from a clinical management perspective and how targeted therapies may address them
Description
ADVENT hosted an engaging educational symposium at EADV 2024 in Amsterdam, where experts, Dedee Murrell, Joost Meijer, Enno Schmidt, and Donna Aline Culton discussed the heterogeneous clinical presentation, disease burden and diagnosis of BP, and its complex pathophysiology involving autoimmunity and type 2 inflammation. The symposium provided a deep dive into unmet needs and treatment challenges faced by these patients and how targeted therapies may address them.
Tags
MAT-GLB-2406805 - 1.0 - 10/2024
About these experts
